The New Era of Precision Medicine in Oncology

SPC Denver Banner 

Denver Divider 

Time change SPC1 

The New Era of Precision Medicine in Oncology |  Didactic Presentation and Panel Discussion                                                                                                                        

ACPE UAN: 0233-0000-17-001-L04-P 

1.5 contact hours | Knowledge-based  

This activity is supported by an independent educational grant from Merck & Co., Inc. 

Advances in cancer genomics have paved the way for a new era of precision medicine in oncology—an era in which a patient’s tumor can be characterized extensively for mutations and other molecular abnormalities, and treatment can be based mainly on the identified molecular changes (not just the type of cancer).  Although these advances are both promising and exciting, clinicians and payers alike are struggling to translate the results of genetic tumor analysis into optimal patient care that provides both superior outcomes and satisfactory value.    This session provides an in-depth look at the reality and promise of precision medicine in oncology.  You will learn the steps involved in going from identifying patients who are candidates for tumor sequencing to making clinical recommendations based on test results.  Along the way, you will become acquainted with the assays used most commonly to characterize tumors and the evidence employed to guide patient-specific treatment options.  A concluding panel discussion will address the many challenges posed to payers by a treatment approach still very much in its infancy.     

Learning Objectives 

At the completion of this activity, participants should be able to:

  1. Define terms used commonly in cancer genomics and precision medicine. 
  2. Identify the people and tasks associated with selecting patients for tumor genetic testing and interpreting test results. 
  3. Explain how an interprofessional molecular tumor board uses information about a patient’s tumor mutations to inform an evidence-based     treatment plan. 
  4. Recognize possible solutions to challenges payers face in melding precision medicine with population management. 


 Final SPC 1  

 Back to SPC Agenda Button                      Register Now button                           Annual Meeting Home page button